HR
BIOR

Howe & Rusling’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Howe & Rusling’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed -$1K – 1051
2021
Q2 		$1K Buy
+1
New +$765 ﹤0.01% 930

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Howe & Rusling's BIOR Position: Q3 2021 in Review

Howe & Rusling sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2021, closing a stake of 1 share — an estimated $1K sold.

Howe & Rusling first reported a position in BIOR in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 35 funds tracked by Wall St. Rank hold BIOR as of Q3 2021.

  • Howe & Rusling reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Howe & Rusling sold 1 Biora Therapeutics, Inc. Common Stock share in Q3 2021, an estimated $1K.
  • Howe & Rusling first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Howe & Rusling's Biora Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Howe & Rusling's 13F filing for Q3 2021, filed 15 Nov 2021.